Canada· CA-DIN-00115630
LIBRAX
A clidinium mit psycholeptika product containing clidinium bromide + chlordiazepoxide hydrochloride, registered in Canada by BAUSCH HEALTH, CANADA INC.. The same ATC class is registered in 5 of our 19 countries.
Checked against Health Canada Drug Product Database (Canada) on
Informational only — not a medical device.
Where it is registered
Clidinium mit psycholeptika is registered in 5 of 19 countries.
Countries holding a registration under ATC A03CA02 (clidinium mit psycholeptika), each read from that country’s own register.
- This record: Canada, from Health Canada Drug Product Database (Canada)
- 4 of them publish a price we can compare per daily dose
Clidinium mit psycholeptika · ATC A03CA02
5 / 19 countries
- Canada
- Finlandprice
- Icelandprice
- Norwayprice
- Switzerlandprice
The record
At a glance
Health Canada Drug Product Database (Canada)- Active substance
- CLIDINIUM BROMIDE + CHLORDIAZEPOXIDE HYDROCHLORIDE
- Manufacturer
- BAUSCH HEALTH, CANADA INC.
- Country
- Canada (CA)
- ATC code
- A03CA02
- ATC class
- Clidinium mit Psycholeptika
- Reimbursed
- Not published by this register
- Source register
- Health Canada Drug Product Database (Canada)
- Last checked
- October 1, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Clidinium mit psycholeptika in 5 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesCHLORDIAZEPOXIDE HCL AND CLIDINIUM BROMIDEMicro Labs Limited
- FranceLIBRAX, comprimé enrobéDIFARMED (ESPAGNE)
- NorwayLibraxMeda
- FinlandLibraxViatris Oy
- United KingdomLibrax capsulesImported (United States)
Authorised across Europe · EMA
The same active substance is authorised in 6 EEA countries. Names it is sold under:
- Cyprus · Bralix, Librax
- Finland · Librax
- France · Librax
- Greece · Librax
- Iceland · Librax
- Portugal · Librax
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Health Canada Drug Product Database (Canada). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/17c53e21-d721-4f17-aa60-8d9ce06a271f GET /v1/drugs/17c53e21-d721-4f17-aa60-8d9ce06a271f?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"din": "00115630",
"form": "CAPSULE",
"class": "Human",
"routes": [
"ORAL"
],
"source": "health_canada_dpd",
"status": "MARKETED",
"atc_raw": "A03CA02",
"schedule": [
"Targeted (CDSA IV)"
],
"drug_code": "728",
"strengths": [
"2.5 MG",
"5 MG"
],
"ahfs_class": null,
"substances": [
"CLIDINIUM BROMIDE",
"CHLORDIAZEPOXIDE HYDROCHLORIDE"
],
"product_categorization": null
}See everything about clidinium mit psycholeptika.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.